DC-S239

N/A

Report date: 2022/02/23 20:00:33
NME

Base Information

Drug NameDC-S239
Drug Alias NameDC-S239
ClassificationOther
Mechanisms of ActionSET Domain Containing 7, Histone Lysine Methyltransferase inhibitors
TargetsSET Domain Containing 7, Histone Lysine Methyltransferase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A